Epicor Cardiac Ablation LP (Low Profile) Thoracotomy Animation

The Epicor LP system has a lower profile (smaller relative to the first generation technology) as well as other features designed to facilitate easier device introduction and placement around and on patients' hearts. In addition, the Epicor LP System is equally suited for use in both closed-chest procedures performed through a single incision, and in open-chest procedures.

In the December 2007 edition of The Annals of Thoracic Surgery, the results of an independent investigator clinical trial led by Mark Groh, M.D., showed that AF is effectively treated using the Epicor Cardiac Ablation System when used concomitantly to corrective heart surgery. The investigators reported that more than 83 percent of all patients, followed for at least six months after surgery, were free from AF. In addition, 86 percent of the patients followed for at least 18 months remained free from AF. The investigators reported that there were no device or ablative procedure-related adverse events and specifically noted an absence of esophageal, coronary or phrenic nerve damage.

The 2007 results confirmed the findings of an earlier European multi-center trial published in the September 2005 Journal of Thoracic and Cardiovascular Surgery. The investigators in the European clinical trial reported an 85 percent freedom-from-AF rate at six months post-procedure - the study's primary efficacy end point - in patients concomitantly treated for AF with the Epicor Cardiac Ablation System.

Category:

Science & Technology

Tags:

• Epicor
• Cardiac
• Ablation
• St.
• Jude
• Medical
• LP

[jonno69098887776766]

HAHAHAHA im no doctor, but...isnt most people's heart on their LEFT SIDE......just thought id throw that out there................

[tomasgrullon]

@jonno69098887776766 

this is a miss conception. the heart is in the middle.

[Aeis25]

@jonno69098887776766 Yeah you're right...you are not a doctor just and idiot